During the last session, Surgery Partners Inc (NASDAQ:SGRY)’s traded shares were 0.79 million, with the beta value of the company hitting 1.83. At the end of the trading day, the stock’s price was $22.04, reflecting an intraday loss of -1.05% or -$0.23. The 52-week high for the SGRY share is $33.97, that puts it down -54.13 from that peak though still a striking 14.38% gain since the share price plummeted to a 52-week low of $18.87. The company’s market capitalization is $2.82B, and the average intraday trading volume over the past 10 days was 1.65 million shares, and the average trade volume was 1.42 million shares over the past three months.
Surgery Partners Inc (SGRY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. SGRY has a Sell rating from 0 analyst(s) out of 8 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it.
Surgery Partners Inc (NASDAQ:SGRY) trade information
Surgery Partners Inc (SGRY) registered a -1.05% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.05% in intraday trading to $22.04, hitting a weekly high. The stock’s 5-day price performance is -0.50%, and it has moved by -5.49% in 30 days. Based on these gigs, the overall price performance for the year is 4.11%. The short interest in Surgery Partners Inc (NASDAQ:SGRY) is 9.41 million shares and it means that shorts have 9.05 day(s) to cover.
The consensus price target of analysts on Wall Street is $38, which implies an increase of 42.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $31 and $64 respectively. As a result, SGRY is trading at a discount of -190.38% off the target high and -40.65% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 10.25%. While earnings are projected to return 10.21% in 2025, the next five years will return 13.35% per annum.
SGRY Dividends
Surgery Partners Inc is due to release its next quarterly earnings on 2025-May-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Surgery Partners Inc (NASDAQ:SGRY)’s Major holders
Surgery Partners Inc insiders own 1.51% of total outstanding shares while institutional holders control 110.89%, with the float percentage being 112.59%. BAIN CAPITAL INVESTORS LLC is the largest shareholder of the company, while 291.0 institutions own stock in it. As of 2024-06-30, the company held over 49.95 million shares (or 39.5983% of all shares), a total value of $1.19 billion in shares.
The next largest institutional holding, with 17.76 million shares, is of FMR LLC’s that is approximately 14.0842% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $422.63 million.
Also, the Mutual Funds coming in first place with the largest holdings of Surgery Partners Inc (SGRY) shares are JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund . Data provided on Mar 31, 2025 indicates that JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund owns about 10.75 shares. This amounts to just over 8.39 percent of the company’s overall shares, with a $237.02 million market value. The same data shows that the other fund manager holds slightly less at 4.6, or about 3.59% of the stock, which is worth about $101.43 million.
